Healthcare provider profile · identity verified

Ashwini P. Gade, MD

Family Practice · PARKER, CO · NPI 1619109972

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	430	69
Furosemide	Furosemide	285	55
Atorvastatin Calcium	Atorvastatin Calcium	275	74
Eliquis	Apixaban	251	38
Amlodipine Besylate	Amlodipine Besylate	190	44
Gabapentin	Gabapentin	174	48
Potassium Chloride	Potassium Chloride	167	38
Metoprolol Succinate	Metoprolol Succinate	164	43
Pantoprazole Sodium	Pantoprazole Sodium	164	46
Losartan Potassium	Losartan Potassium	152	37
Lisinopril	Lisinopril	147	40
Rosuvastatin Calcium	Rosuvastatin Calcium	147	23
Sertraline Hcl	Sertraline Hcl	139	34
Trazodone Hcl	Trazodone Hcl	134	30
Metformin Hcl	Metformin Hcl	131	27
Tamsulosin Hcl	Tamsulosin Hcl	120	41
Levetiracetam	Levetiracetam	98	22
Xarelto	Rivaroxaban	88	20
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	84	36
Donepezil Hcl	Donepezil Hcl	83	12
Mirtazapine	Mirtazapine	71	20
Ondansetron Hcl	Ondansetron Hcl	66	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	19
Clopidogrel	Clopidogrel Bisulfate	61	19
Omeprazole	Omeprazole	60	17
Escitalopram Oxalate	Escitalopram Oxalate	58	17
Finasteride	Finasteride	58	15
Metoprolol Tartrate	Metoprolol Tartrate	55	16
Duloxetine Hcl	Duloxetine Hcl	53	18
Baclofen	Baclofen	51	16
Olanzapine	Olanzapine	51	17
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	50	50
Hydrochlorothiazide	Hydrochlorothiazide	49	12
Metformin Hcl Er	Metformin Hcl	48	12
Ropinirole Hcl	Ropinirole Hcl	48	suppressed
Simvastatin	Simvastatin	48	suppressed
Topiramate	Topiramate	47	suppressed
Pregabalin	Pregabalin	46	19
Spironolactone	Spironolactone	45	14
Levofloxacin	Levofloxacin	44	33
Prednisone	Prednisone	44	33
Carbidopa-Levodopa	Carbidopa/Levodopa	43	suppressed
Risperidone	Risperidone	43	16
Carvedilol	Carvedilol	42	13
Myrbetriq	Mirabegron	42	suppressed
Cephalexin	Cephalexin	40	24
Glycopyrrolate	Glycopyrrolate	40	suppressed
Meloxicam	Meloxicam	40	suppressed
Nystatin	Nystatin	40	18
Divalproex Sodium	Divalproex Sodium	37	13
Quetiapine Fumarate	Quetiapine Fumarate	37	16
Divalproex Sodium Er	Divalproex Sodium	36	suppressed
Lamotrigine	Lamotrigine	36	suppressed
Alendronate Sodium	Alendronate Sodium	35	suppressed
Buspirone Hcl	Buspirone Hcl	35	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	34	34
Methocarbamol	Methocarbamol	34	12
Lorazepam	Lorazepam	33	20
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Lubiprostone	Lubiprostone	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Midodrine Hcl	Midodrine Hcl	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	12
Aripiprazole	Aripiprazole	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	17
Lactulose	Lactulose	27	suppressed
Latanoprost	Latanoprost	27	11
Memantine Hcl	Memantine Hcl	27	suppressed
Metolazone	Metolazone	27	suppressed
Scopolamine	Scopolamine	27	suppressed
Jardiance	Empagliflozin	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	16
Tramadol Hcl	Tramadol Hcl	25	14
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	16
Creon	Lipase/Protease/Amylase	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	16
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	16
Albuterol Sulfate Hfa	Albuterol Sulfate	23	16
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	22	suppressed
Fluconazole	Fluconazole	22	15
Ingrezza	Valbenazine Tosylate	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Budesonide	Budesonide	21	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	21	11
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Torsemide	Torsemide	21	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	12
Lacosamide	Lacosamide	20	suppressed
Nystop	Nystatin	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Allopurinol	Allopurinol	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	11
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Ozempic	Semaglutide	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	11
Linzess	Linaclotide	15	suppressed
Timolol Maleate	Timolol Maleate	15	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Famotidine	Famotidine	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Montelukast Sodium	Montelukast Sodium	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Glucagon Emergency Kit	Glucagon Hcl	12	12
Metronidazole	Metronidazole	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Lidocaine Hcl	Lidocaine Hcl	11	suppressed
Lurasidone Hcl	Lurasidone Hcl	11	suppressed
Mirabegron Er	Mirabegron	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error